{"transactions":[{"id":723031,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2026-06-30T21:25:10.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":7304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to Reporting Person of options exercisable as of April 25, 2025."}],"balance_after":1500,"derivative":{"exercise_price":38.46,"expiration_date":"2034-04-25","underlying":"Common Stock","underlying_shares":7304},"source":{"system":"sec-edgar","filing":"0001159036-26-000082","document":"wk-form4_1782854707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000082/wk-form4_1782854707.xml","form_type":"4"}},{"id":723030,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T21:25:10.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":7304,"price":75,"value":547800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 19, 2026 in accordance with Rule 10b5-1."}],"balance_after":14462,"source":{"system":"sec-edgar","filing":"0001159036-26-000082","document":"wk-form4_1782854707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000082/wk-form4_1782854707.xml","form_type":"4"}},{"id":723029,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T21:25:10.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":7304,"price":38.46,"value":280911.84,"ownership":{"direct":true},"balance_after":21766,"source":{"system":"sec-edgar","filing":"0001159036-26-000082","document":"wk-form4_1782854707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000082/wk-form4_1782854707.xml","form_type":"4"}},{"id":788728,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2026-05-07T23:04:01.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":6040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":6040,"derivative":{"exercise_price":65.87,"expiration_date":"2036-05-05","underlying":"Common Stock","underlying_shares":6040},"source":{"system":"sec-edgar","filing":"0001159036-26-000063","document":"wk-form4_1778195038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000063/wk-form4_1778195038.xml","form_type":"4"}},{"id":788727,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-07T23:04:01.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":3796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program. Each RSU represents the right to receive one share of common stock of the Issuer. This grant will vest in full on the earlier of (i) May 5, 2027 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":14462,"source":{"system":"sec-edgar","filing":"0001159036-26-000063","document":"wk-form4_1778195038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000063/wk-form4_1778195038.xml","form_type":"4"}},{"id":1161478,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-05-02T20:08:05.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":5750,"derivative":{"exercise_price":60.03,"expiration_date":"2035-05-01","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-011773","document":"form4-05022025_080502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588925011773/form4-05022025_080502.xml","form_type":"4"}},{"id":1161477,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-02T20:08:05.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":4165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":10666,"source":{"system":"sec-edgar","filing":"0001415889-25-011773","document":"form4-05022025_080502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588925011773/form4-05022025_080502.xml","form_type":"4"}},{"id":1533932,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-04-29T22:01:02.000Z","date":"2024-04-25","kind":"grant","planned":false,"acquired":true,"shares":8804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":8804,"derivative":{"exercise_price":38.46,"expiration_date":"2034-04-25","underlying":"Common Stock","underlying_shares":8804},"source":{"system":"sec-edgar","filing":"0001415889-24-011692","document":"form4-04292024_100456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588924011692/form4-04292024_100456.xml","form_type":"4"}},{"id":1533931,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-29T22:01:02.000Z","date":"2024-04-25","kind":"grant","planned":false,"acquired":true,"shares":6501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":6501,"source":{"system":"sec-edgar","filing":"0001415889-24-011692","document":"form4-04292024_100456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588924011692/form4-04292024_100456.xml","form_type":"4"}},{"id":1809826,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:10:52.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4401,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on April 2, 2023.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on April 2, 2023.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on April 2, 2023.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4401},"source":{"system":"sec-edgar","filing":"0001209191-23-045428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045428/doc4.xml","form_type":"4"}},{"id":1809825,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:10:52.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26600,"price":23.26,"value":618716.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award, which provided for ratable vesting in 36 monthly installments beginning on May 2, 2022, became fully vested and was canceled upon effectiveness of the Merger , and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":16.74,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":26600},"source":{"system":"sec-edgar","filing":"0001209191-23-045428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045428/doc4.xml","form_type":"4"}},{"id":1809824,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-11T16:10:52.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were disposed of pursuant to the Merger Agreement (defined in the Remarks below).  Upon effectiveness of the Merger (defined in the Remarks below), in exchange for each share of the Issuer's Common Stock, the reporting person received:  (i) $40.00 in cash, without interest and less applicable withholding taxes; and (ii) one contractual contingent value right (each, a \"CVR\"), entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement (the \"Contingent Value Rights Agreement\") entered into concurrent with completion of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-045428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045428/doc4.xml","form_type":"4"}},{"id":1927843,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-04T21:14:45.000Z","date":"2023-04-01","kind":"exercise","planned":true,"acquired":false,"shares":2199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on April 1, 2023, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":4401,"derivative":{"expiration_date":"2025-04-04","underlying":"Common Stock","underlying_shares":2199},"source":{"system":"sec-edgar","filing":"0001209191-23-023108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123023108/doc4.xml","form_type":"4"}},{"id":1927842,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T21:14:45.000Z","date":"2023-04-04","kind":"sale","planned":true,"acquired":false,"shares":924,"price":23.01,"value":21261.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated February 10, 2023."}],"balance_after":1275,"source":{"system":"sec-edgar","filing":"0001209191-23-023108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123023108/doc4.xml","form_type":"4"}},{"id":1927841,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T21:14:45.000Z","date":"2023-04-01","kind":"exercise","planned":true,"acquired":true,"shares":2199,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":2199,"source":{"system":"sec-edgar","filing":"0001209191-23-023108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123023108/doc4.xml","form_type":"4"}},{"id":2304116,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock (RSU)(Common Stock)","published_at":"2022-04-05T18:47:39.000Z","date":"2022-04-02","kind":"grant","acquired":true,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on April 2, 2023, until fully vested subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":6600,"derivative":{"expiration_date":"2025-04-02","underlying":"Common Stock","underlying_shares":6600},"source":{"system":"sec-edgar","filing":"0001209191-22-023291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122023291/doc4.xml","form_type":"4"}},{"id":2304115,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34532,"kind":"person","name":"Krishnan Mahesh","position":1,"cik":"0001866746","reported_name":"Krishnan Mahesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-05T18:47:39.000Z","date":"2022-04-02","kind":"grant","acquired":true,"shares":26600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option fully vests as to 1/36 of the total shares monthly beginning on May 2, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":26600,"derivative":{"exercise_price":16.74,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":26600},"source":{"system":"sec-edgar","filing":"0001209191-22-023291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122023291/doc4.xml","form_type":"4"}}]}